Skip to content

Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings for the Diagnosis of Either Acute Kidney Injury or Chronic Kidney Disease in Routine Practices (NEPHROCT)

Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings for the Diagnosis of Either Acute Kidney Injury or Chronic Kidney Disease in Routine Practices

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05728216
Acronym
NEPHROCT
Enrollment
50
Registered
2023-02-15
Start date
2022-11-01
Completion date
2028-11-30
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Chronic Kidney Diseases, Tomography, Optical Coherence

Keywords

Tomography, Optical Coherence, Chronic Kidney Diseases, Acute Kidney Injury, Kidney Biopsy

Brief summary

Kidney biopsy play a key role for the investigation of either acute kidney injury or chronic kidney disease. Despite possible complications due to the invasive nature of the biopsy, such procedure is still essential in a number of clinical situations to improve the diagnosis specificity of kidney disease, better inform about its prognosis and guide the management of a future treatment. Pursuing the idea to improve both performance and rapidity associated with the histopathological analysis of kidney biopsy, with a possible recourse to artificial intelligence-based renal pathology, the present study intends to assess the impact of direct histopathological examination of kidney biopsy with dynamic full-field optical coherence tomography in routine practices for the diagnosis of either acute kidney injury or chronic kidney disease.

Interventions

OTHERDynamic full-field optical coherence tomography analysis of kidney biopsy

Dynamic full-field optical coherence tomography analysis of kidney biopsy in the nephrology department before conventional histopathological analysis

Sponsors

Centre Hospitalier William Morey - Chalon sur Saône
Lead SponsorOTHER
Centre Hospitalier Universitaire Dijon
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* patients \> 18 years of age with suspected acute kidney injury requiring biopsy in the nephrology department * patients \> 18 years of age with suspected chronic kidney disease requiring biopsy in the nephrology department

Exclusion criteria

* inability to perform dynamic full-field optical coherence tomography observation at the moment of kidney biopsy

Design outcomes

Primary

MeasureTime frameDescription
Histopathological analysis of elementary lesions in nephropathology with dynamic full-field optical coherence tomographyOutcome measure is assessed 15 days following kidney biopsyProvide a better understanding of the ability of dynamic full-field optical coherence tomography to identify and characterize common glomerular (abnormal / double contour of the glomerular basement membrane, focal segmental glomerulosclerosis, collapse of the glomerular tuft, proliferation of glomerular epithelial cells, endocapillary proliferation, mesangial expansion, necrosis and proliferation with mild increase in extracapillary cells...), vascular (hyaline change, fibrinoid change / necrosis, thrombosis, inflammation or necrosis of vascular walls, arteriosclerosis) and tubulointerstitial (acute tubular necrosis, cytoplasmic vacuolization, lipid inclusions in proximal / distal tubular cells, atrophy of tubules, edema, inflammation or interstitial fibrosis, cortical necrosis) lesions seen in kidney biopsy

Secondary

MeasureTime frameDescription
Histopathological analysis of healthy kidney biopsy with dynamic full-field optical coherence tomographyOutcome measure is assessed 15 days following kidney biopsyProvide a better understanding of the ability of dynamic full-field optical coherence tomography to identify and characterize healthy glomerular (glomerular basement membrane, glomerular tuft, endothelial, epithelial, and mesangial cells, glomerular capsule and capsular space, glomerular capillaries), vascular (afferent and efferent arterioles, interlobular artery) and tubulointerstitial (proximal and distal tubular cells, normal cytoplasmic aspect) structures seen in kidney biopsy

Countries

France

Contacts

CONTACTThomas Maldiney
thomas.maldiney@ch-chalon71.fr+33 3 85 91 01 11
CONTACTQuentin Bernard
quentin.bernard@ch-chalon71.fr
PRINCIPAL_INVESTIGATORThomas Maldiney

Centre Hospitalier William Morey - Chalon sur Saône

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026